Supplementary Data: Figures S1-S6 and Tables S1-S6 from Inferred Immune-Cell Activity is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial